Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

CV Therapeutics moves CVT-510 to phase III

May 19, 2000

Specific beta1-adrenoceptor blockade with antisense oligonucleotides for hypertension

May 18, 2000

Protherics' high blood pressure vaccine moves to next phase

May 18, 2000

New calcium antagonists designed by Chinese university researchers

May 18, 2000

Two potent and selective iNOS inhibitors discovered by Glaxo Wellcome

May 17, 2000

Japanese patent covers Kanebo's new Na+/H+ exchange inhibitors

May 17, 2000

New series of ECE inhibitors in early development by Sumitomo

May 17, 2000

Uniprost to be marketed by Ferrer in Europe and Latin America

May 17, 2000

Free radical scavenger T-0162 protects against ischemia/reperfusion myocardial injury

May 16, 2000

PCO prodrugs with slow onset and long duration of action presented by Daiichi

May 16, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...